One-off donation (in memory)
Monthly donation (in memory)
Your research stories
Mesothelioma research update April 2021
Ian from our research team talks about the progress that our researchers have been making towards better treatments for mesothelioma.
Identifying those at risk of COPD
Gavin is a professor in respiratory studies at Imperial College London. He's working on a study that hopes to identify people at risk of developing COPD in order to treat it early.
Ground-breaking research from the European Respiratory Society Congress
Ian, from our research team, attending this year's virtual European Respiratory Society Annual Congress. Here he discusses his highlights from the conference and how our funding is helping young researchers share their work.
How COVID-19 has created new opportunities for respiratory research and innovation
As the annual ERS Congress takes place, virtually of course, Kay Boycott (Chief Executive of Asthma UK and British Lung Foundation) considers the opportunity presented by COVID-19 to drive forward game-changing research and innovation for respiratory disease.
We’re working on an urgently needed treatment for IPF
Professor Robin McAnulty is working on a research project that seeks to find a potential treatment for pulmonary fibrosis.
Identifying new ways to treat mesothelioma
In their research, Samantha Arathimou (PhD student) and Professor Sam Janes wanted to find out more about the pleura (lung lining) and mesothelioma cells, to understand more about the early stages of developing mesothelioma.
I was left on my own after diagnosis
Lauren has asthma. Her diagnosis journey left her confused about her condition. She tells her story and explains why things need to change.
Although lung disease has just as great an impact on the nation’s health as heart disease or cancer, it receives only 2% of UK charity medical spend. In contrast, 30% is spent on cancer and over 10% on heart disease. We can’t let this situation continue. Please donate now.Ian, our head of research